SRX is a failure where as OncoSil has already proven complete response in some patients. Sell off is absurd imo.
Response of HHC Target Tumour after Single Fixed Dose of OncoSilTM
+WHO definitions of tumour response * Denotes investigator’s classification. A change of -100% indicated total disappearance of target lesions
Patient Number % Change in target Tumour Volume Response+ 001 -44% Stable Disease 002 -80% Partial Response 003 -16% Stable Disease 004 -43% Partial Response 005 -100% Complete Response 006 -100% Complete Response 007 -100% Complete Response 008 -35% Stable Disease
SRX is a failure where as OncoSil has already proven complete...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9286 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 412 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |